Somerville Kurt F Abb Vie Inc. Transaction History

Somerville Kurt F

$582 Million
Q2 2024

A detailed history of Somerville Kurt F transactions in Abb Vie Inc. stock. As of the latest transaction made, Somerville Kurt F holds 7,452 shares of ABBV stock, worth $1.44 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

7,452

Previous 7,477 0.33%

Holding current value

$1.44 Million

Previous $1.36 Million 6.1%

% of portfolio

0.22%

Previous 0.24%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $3,869 - $4,519	-25 Reduced 0.33%	7,452 $1.28 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $13,897 - $15,651	-101 Reduced 1.33%	7,477 $1.16 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $33,130 - $38,353	-248 Reduced 3.17%	7,578 $1.13 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $1.13 Million - $1.4 Million	-8,496 Reduced 52.05%	7,826 $1.05 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $34,706 - $39,969	-240 Reduced 1.45%	16,322 $2.6 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $38,920 - $44,639	-290 Reduced 1.72%	16,562 $2.22 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $187,988 - $238,995	-1,366 Reduced 7.5%	16,852 $2.58 Million
Q1 2022 May 17, 2022	SELL	$131.98 - $163.75 $209,584 - $260,035	-1,588 Reduced 8.02%	18,218 $2.95 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $6,445 - $8,155	-60 Reduced 0.3%	19,806 $2.68 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $21,280 - $24,156	-200 Reduced 1.0%	19,866 $2.14 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $75,225 - $83,805	-715 Reduced 3.44%	20,066 $2.26 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $47,671 - $52,480	466 Added 2.29%	20,781 $2.25 Million
Q3 2020 Oct 28, 2020	SELL	$85.91 - $100.83 $176,974 - $207,709	-2,060 Reduced 9.21%	20,315 $1.78 Million
Q2 2020 Jul 28, 2020	BUY	$73.37 - $98.18 $132,066 - $176,724	1,800 Added 8.75%	22,375 $2.2 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $54,825 - $83,121	-850 Reduced 3.97%	20,575 $1.57 Million
Q4 2019 Jan 15, 2020	SELL	$72.13 - $90.25 $125,145 - $156,583	-1,735 Reduced 7.49%	21,425 $1.9 Million
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $65,700 - $83,980	-1,000 Reduced 4.14%	23,160 $1.68 Million
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $77,140 - $90,790	-1,000 Reduced 3.97%	24,160 $1.95 Million
Q4 2018 Jan 24, 2019	SELL	$77.85 - $96.01 $7,784 - $9,601	-100 Reduced 0.4%	25,160 $2.32 Million
Q3 2018 Oct 15, 2018	SELL	$88.91 - $98.84 $6,668 - $7,413	-75 Reduced 0.3%	25,260 $2.39 Million
Q2 2018 Jul 30, 2018	SELL	$89.78 - $106.23 $134,670 - $159,345	-1,500 Reduced 5.59%	25,335 $2.35 Million
Q1 2018 Apr 24, 2018	SELL	$92.01 - $123.21 $112,068 - $150,069	-1,218 Reduced 4.34%	26,835 $2.54 Million
Q4 2017 Feb 02, 2018	SELL	$89.56 - $98.21 $98,247 - $107,736	-1,097 Reduced 3.76%	28,053 $2.71 Million
Q3 2017 Oct 26, 2017	BUY	$69.85 - $89.22 $2.04 Million - $2.6 Million	29,150	29,150 $2.59 Million

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerville Kurt F, based on Form 13F filings with the SEC.

News

Stay updated on Somerville Kurt F with notifications on news.

Account

Somerville Kurt F Abb Vie Inc. Transaction History